COO NASDAQ Week ended 31 Jul 2026

Weekly Investor Report

The Cooper Companies, Inc · Healthcare · Medical Instruments & Supplies

Open interactive chart View report data
Latest close 72.32 USD
2.9% latest week
Weekly setup

Weak trend

The weekly trend is not active. Price is 0.4% above the Trend Line and sits at 43.4% of its 52-week range. The latest completed week returned 2.9%, after a -2.5% four-week move. The latest factor snapshot indicates quality is middle-of-the-pack; growth ranks weakly; valuation is expensive relative to peers. Options positioning is bullish with 42/100 conviction, while the latest news-sentiment score is 51/100. Near-term considerations: volume confirmation is below normal; earnings are due in 24d.

Setup score 38 out of 100
Latest Close 72.32 USD 31 Jul 2026
1W Return 2.9% latest completed week
4W Return -2.5% short-term follow-through
12W Return 20.5% quarterly tape
Trend Breadth 26.9% 14 of 52 weeks active
Volume Ratio 0.7x vs 13-week average
What is working
  • Price is above the Trend Line, keeping the weekly tape constructive.
  • Activity pressure is positive on the latest completed week.
What could go wrong
  • The trend backdrop is inactive, so price action has not confirmed a constructive regime.
  • Price is below Fair Value, so the market is still discounting the latest tape.
  • Activity pressure is weak, so confirmation is not yet broad enough.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through 2.9% Latest completed week; four-week move -2.5%. Indicator stack 15/56 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Recent Activity-pressure buy-signal status for institutional accumulation timing. Options pressure Bullish 42/100 conviction; expected move 8.5%. News sentiment 51/100 51 relevant articles in the latest sentiment read. Event risk 24d Next report is scheduled for 26 Aug 2026; event risk rises as the date approaches.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is not active. Price is 0.4% above the Trend Line and sits at 43.4% of its 52-week range. The latest completed week returned 2.9%, after a -2.5% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 0.7x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.3012-week average 0.13

12-week confirmation

Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure6/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.30Current proprietary activity-pressure read.
Buy signals1Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers

No recent accumulation markers. No reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is -2.5% over four weeks, 20.5% over 12 weeks, and 2.0% over one year. The current trend has remained active for 0 consecutive weeks.

Performance by holding period

1W2.9%
4W-2.5%
12W20.5%
26W-11.1%
52W2.0%
Active trend streak0 weeks
Active weeks in one year14
Trend breadth26.9%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure0.43Latest activity-pressure read.
Pressure change-17.6%Four-week change in activity pressure.
Leadership-9.34Latest relative-leadership reading.
RS change21.6%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality is middle-of-the-pack; growth ranks weakly; valuation is expensive relative to peers.

Open full factor analysis
Factor week 26 Jul 2026 Financial statements through 30 Apr 2026 Field coverage 100% Model confidence 100%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength14/100Blend of value, momentum, and quality. Underlying universe rank 87; rank 1 is best.
Value15/100Relative valuation strength. Underlying universe rank 86; rank 1 is best.
Quality74/100Profitability and accounting quality. Underlying universe rank 27; rank 1 is best.
Momentum23/100Medium-term price momentum. Underlying universe rank 78; rank 1 is best.
Growth13/100Revenue and earnings growth. Underlying universe rank 88; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Value-quality framework20/100Value and quality alignment from the Sharemaestro SVQF framework.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
58.2x
Price divided by trailing earnings.
Price / sales
3.2x
Market value relative to trailing revenue.
EV / EBITDA
18.5x
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
8.3%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
64.4%
Gross profit retained from each unit of revenue.
Operating margin
11.4%
Operating profit retained from revenue.
Free-cash-flow margin
31.6%
Free cash flow generated from revenue.
Return on invested capital
2.6%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
6.1%
Latest one-year revenue growth.
EPS growth
-43.1%
Latest one-year earnings-per-share growth.
Free-cash-flow growth
15.3%
Latest one-year free-cash-flow growth.
Piotroski F-score
6/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
0.0%
Cash dividends relative to market value.
Buyback yield
2.6%
Net share repurchases relative to market value.
Shareholder yield
2.6%
Dividend yield plus net buyback yield.
Net debt / EBITDA
2.7x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Options positioningBullish

COO shows bullish options pressure with a 42/100 conviction score, put-call volume ratio of 0.35, expected move of 8.5%, and Sharemaestro trend signal inactive.

Conviction42/100
Expected move8.5%
Put/call volume0.35
Pressure54
Speculation42
Volatility54
Trend agreement19
Open options detail
Insider activity14 / 6

14 acquisitions and 6 disposals in the latest 180-day insider tape.

Acquisitions / disposals over the latest 180 days. Insider activity is context, not a stand-alone signal.
News sentiment51/100

Weighted news tone is neutral across 51 relevant articles.

7 positive · 40 neutral · 4 negative
Patient CapitalRecent

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

Recent buy signal in the last 8 weeks
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings24dNext report is scheduled for 26 Aug 2026; event risk rises as the date approaches.
Options expected move8.5%Nearest-chain priced movement where available.
52-week drawdown-19.5%Distance below the 52-week high.
13-week volatility4.4%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher13 of 2613 weeks finished lower.
Best week+10.0%Week of 5 Jun.
Worst week-8.7%Week of 13 Mar.
Latest week+2.9%Week of 31 Jul.

Shape of recent returns

Strong gains4
Modest gains9
Flat weeks0
Modest losses9
Sharp losses4
Recent vol4.4%13-week weekly-return volatility.
Base vol3.9%52-week weekly-return volatility.
Up/down split29/23Count of positive and negative weeks in the 52-week window.
Average skew2.7% / -3.2%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape34/100

Trend, activity pressure, participation, and risk combine to a 34/100 tape read.

 Indicator analysis24/100

Latest 12-week confirmation: trend 0/12, activity pressure 6/12, relative leadership 0/12.

Activity pressure 0.30; No reversal markers Factors31/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 20; Small Cap Core rank 80 SVQF20/100

Value and quality alignment from the Sharemaestro SVQF framework.

Composite rank 580.5 of 726 Patient CapitalRecent

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

Recent buy signal in the last 8 weeks Options48/100

COO shows bullish options pressure with a 42/100 conviction score, put-call volume ratio of 0.35, expected move of 8.5%, and Sharemaestro trend signal inactive.

Bullish · Call-side pressure · Expected move 8.5% Sentiment51/100

Weighted news tone is neutral across 51 relevant articles.

Vivani Medical (NASDAQ: VANI) grants COO options and performance RSUs Insiders14 / 6

14 acquisitions and 6 disposals in the latest 180-day insider tape.

 Earnings24d

Next report is scheduled for 26 Aug 2026; event risk rises as the date approaches.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
31 Jul 202672.32 USD2.9%72.02 USD84.44 USD0.43-9.349.6MOff
24 Jul 202670.31 USD-2.0%72.31 USD84.60 USD0.53-11.729.9MOff
17 Jul 202671.71 USD1.4%72.72 USD84.78 USD0.63-11.839.4MOff
10 Jul 202670.70 USD-4.7%73.09 USD84.94 USD0.56-17.0512.0MOff
3 Jul 202674.20 USD4.5%73.47 USD85.12 USD0.52-11.9215.0MOff
26 Jun 202671.02 USD7.8%73.71 USD85.25 USD0.33-15.3516.2MOff
19 Jun 202665.91 USD-2.9%73.94 USD85.41 USD-0.12-25.3412.9MOff
12 Jun 202667.88 USD0.8%74.26 USD85.59 USD-0.37-21.6019.6MOff
5 Jun 202667.34 USD10.0%74.40 USD85.74 USD-0.74-20.9225.6MOff
29 May 202661.21 USD-2.1%74.49 USD85.86 USD-1.04-31.8011.9MOff
22 May 202662.55 USD4.9%74.78 USD86.04 USD-1.03-28.8512.0MOff
15 May 202659.61 USD-0.7%75.15 USD86.23 USD-1.08-32.0911.0MOff
8 May 202660.00 USD-3.8%75.56 USD86.47 USD-1.03-32.6612.1MOff
1 May 202662.36 USD-3.2%75.84 USD86.71 USD-0.98-27.1112.2MOff
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.